A master service agreement can shape a testing relationship for years. Evaluating a contract testing laboratory before signing means looking past capability lists and pricing. Operational details determine how the relationship runs once samples are already in the queue: how a lab handles inspections, data, communication, and delays. Five targeted due diligence questions can reveal these details before you sign.
Key Takeaways
- FDA inspection history predicts future reliability — Ask for inspection dates, classifications, and how observations were resolved, going beyond certification logos.
- Data integrity depends more on system design than policy language — LIMS access controls and audit trail capture matter more than a written data integrity policy.
- A named project manager changes the day-to-day experience — A dedicated contact with direct visibility into your samples outperforms a shared support queue.
- Method ownership terms determine future flexibility — Confirm you retain full validation data rather than assuming rights to your own methods.
- Turnaround benchmarks should reflect real, current capacity — Ask about current queue length and peak-period timelines to get accurate benchmarks.
What to Evaluate Before Committing to a Contract Testing Laboratory
The questions below address the areas most likely to complicate a relationship with a pharmaceutical testing services provider: regulatory standing, data handling, communication structure, method ownership, and scheduling reality.
1. What Is This Contract Testing Laboratory’s Inspection History?
Specifics on inspection history carry more weight than accreditation logos alone.
What to Ask
- Date of the most recent FDA inspection and its classification (No Action Indicated, Voluntary Action Indicated, or Official Action Indicated)
- What corrective actions were taken if observations were issued, and how the lab confirmed the finding was closed
- Which specific test methods fall under the lab’s current certifications, since ISO/IEC 17025 accreditation applies only to the specific methods within its defined scope
The Limits of a Clean Inspection Record
A documented CAPA process says more about ongoing reliability than a clean inspection record alone. Certification scope gaps are easy to miss until a submission is already underway, so confirming both in advance avoids a surprise mid-program.
2. How Is Data Integrity Maintained Across the LIMS?
Electronic records, audit trails, and system access controls sit at the center of most cGMP data integrity findings, per FDA’s guidance on data integrity and cGMP compliance.
What to Ask
- How audit trails are reviewed, and by whom
- Who holds administrative access to the LIMS
- How electronic records meet 21 CFR Part 11 requirements for signatures and record integrity
- How quickly raw data and audit trails can be produced during a client audit or regulatory inspection
System Design Over Written Policy
A lab on a modern LIMS platform with role-based access controls and automated audit trail capture is generally better positioned to support this than a lab relying on manual logbooks or spreadsheets for part of its workflow.
3. What Does the Project Management Model Look Like?
A single point of contact changes how a project runs day to day.
What to Ask
- Whether you’ll work with a dedicated project manager with direct visibility into your samples, or a shared queue answered by whoever is available
- How escalations are handled when a result is delayed, and whether that path involves a named person or a general support inbox
- How the lab maintains continuity if your assigned project manager changes roles or leaves mid-program
The Cost of a Shared Support Queue
A shared queue adds latency to routine requests, since the response depends on who happens to be available rather than someone with direct context on your program. Client feedback on responsiveness is often a better predictor of this than anything in a capabilities deck.
4. How Does Method Transfer and Method Ownership Work?
Method ownership terms determine what happens if the relationship ends or the program moves to a different lab.
What to Ask
- Whether your organization retains full rights to the validation package, or whether methods are built on a proprietary platform tied to that lab’s specific instrumentation
- What a complete method transfer package includes: development rationale, full validation data across relevant ICH parameters, and instrument or matrix-specific notes
- How method transfer to a receiving lab is typically structured, including protocol and acceptance criteria documentation
What a Summary Report Leaves Out
Documentation habits established during analytical development and validation tend to carry through to how a method transfer package looks later. A final summary report reconstructs a method only partially compared to the full validation history.
5. What Are Realistic Turnaround Time Benchmarks?
Marketing materials tend to list best-case turnaround times.
What to Ask
- Current queue length by test type, and how it shifts during peak submission periods
- What proactive notification looks like when a result will be late
- Whether rush or expedited testing is available, and how that affects standard-priority work already in the queue
- A turnaround range for the specific test types your program relies on most, more informative than a single average across the lab’s full service list
Verifying Real Capacity
A lab with established facilities and enough scientific staff to absorb volume swings without pushing every project to the back of the line is worth confirming directly with the lab, since a services page rarely reflects current queue length.
Turning These Questions Into MSA Language
Verbal answers to these questions are useful during due diligence, but they carry more weight once they’re written into the agreement itself. Terms worth specifying directly in the MSA include:
- A data integrity clause referencing audit trail review and electronic record retention standards
- A named project manager with defined escalation timelines
- Explicit method ownership language
- Turnaround commitments defined by sample type, rather than as a single blanket estimate
Why This Matters at Renewal
- The people who negotiated the original agreement, on your team or the lab’s, often move roles by the time renewal or expansion comes around
- Written terms survive staff turnover better than informal understanding
- Vague MSAs tend to surface gaps under time pressure: a submission deadline, an unexpected inspection, or a scale-up that stresses capacity beyond what the agreement anticipated
Selecting a contract testing laboratory at the decision stage comes down to confirming that operational practices match what a proposal describes. The five questions above, backed by documentation, give QA and operations leads a concrete basis for that comparison before signature.
Common Questions About Master Service Agreements With a Testing Lab
What should an MSA include beyond testing services and pricing?
A complete MSA typically addresses:
- Confidentiality and data ownership
- Liability and insurance terms
- The process for terminating or transitioning out of the agreement
These terms rarely come up during technical evaluation but matter once a program is underway.
How are contract testing lab engagements typically priced?
Pricing usually follows either a per-project rate card or a negotiated structure tied to anticipated volume across the relationship. We maintain open lines of communication throughout the project and discuss any changes to scope, volume, or pricing as needed.
What should we evaluate during a technical audit of contract lab services?
A technical audit typically covers recordkeeping practices, instrument qualification and calibration records, and how the lab manages deviations and out-of-specification results. Many labs allow an on-site visit or virtual walkthrough during due diligence so QA teams can assess these firsthand.
How quickly can a project start once an MSA is signed?
Most labs can begin work within days of receiving completed sample submission forms and required documentation, though the exact timeline depends on test type and current queue length. A dedicated project manager typically coordinates this kickoff and confirms an initial turnaround estimate.
Does signing an MSA commit us to a minimum volume of work?
Some MSAs include minimum volume or spend commitments, while others function as a framework where obligations begin once individual work orders are issued. Confirming which structure applies before signature matters most for programs that expect their testing needs to change.
Evaluating Your Next Testing Partner
BA Sciences answers these questions directly: documented FDA inspection history, a dedicated single point-of-contact project manager, LabWare LIMS-based data integrity controls, and method transfer packages that keep validation data with the client. Request a quote to discuss your testing program and MSA requirements.
Read More:
5 Considerations When Choosing an Analytical Testing Lab
How to Develop a Great Working Relationship with Your CRO
What You Give Up When You Outsource to a Large CRO — and What to Look For Instead